Sentry Investment Management LLC Sells 120 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Sentry Investment Management LLC lowered its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 14.0% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 740 shares of the medical device company’s stock after selling 120 shares during the quarter. Sentry Investment Management LLC’s holdings in Cooper Companies were worth $68,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in COO. Allworth Financial LP raised its stake in shares of Cooper Companies by 45.8% in the 3rd quarter. Allworth Financial LP now owns 968 shares of the medical device company’s stock valued at $107,000 after acquiring an additional 304 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its holdings in Cooper Companies by 25.0% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 17,833 shares of the medical device company’s stock valued at $1,958,000 after purchasing an additional 3,566 shares during the last quarter. Arkadios Wealth Advisors bought a new position in shares of Cooper Companies in the third quarter valued at approximately $277,000. Wealth Enhancement Advisory Services LLC lifted its stake in shares of Cooper Companies by 33.3% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 9,061 shares of the medical device company’s stock worth $1,000,000 after buying an additional 2,264 shares during the last quarter. Finally, State of Alaska Department of Revenue boosted its holdings in shares of Cooper Companies by 1.5% during the 3rd quarter. State of Alaska Department of Revenue now owns 24,142 shares of the medical device company’s stock worth $2,663,000 after buying an additional 355 shares during the period. Institutional investors own 24.39% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently commented on COO shares. Morgan Stanley dropped their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Citigroup dropped their price target on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research report on Friday, December 6th. Finally, Wells Fargo & Company upped their price target on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $117.00.

Cooper Companies Stock Performance

Shares of NASDAQ COO opened at $89.87 on Friday. The firm has a market capitalization of $17.94 billion, a price-to-earnings ratio of 46.09, a PEG ratio of 2.25 and a beta of 1.00. The Cooper Companies, Inc. has a one year low of $84.76 and a one year high of $112.38. The business has a fifty day simple moving average of $92.71 and a 200 day simple moving average of $99.49. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. The company had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business’s revenue was up 9.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.87 EPS. Sell-side analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.